First-Level vs. Second-Level Appeals: Strategy Differences

Not all appeals are created equal, and treating them as interchangeable is one of the most common mistakes in denial management. A first-level appeal and a second-level appeal serve different purposes, are reviewed by different people, and require different strategies. Practices that submit essentially the same appeal at both levels are wasting their second chance — and in many cases, their last internal opportunity to recover the denied revenue.

Understanding the strategic differences between appeal levels is essential for maximizing your overturn rate and making informed decisions about when escalation is worth the investment.

How the Appeal Levels Work

Most commercial payers and all Medicare Advantage plans offer a multi-level internal appeal process before a claim moves to external review. The structure typically looks like this:

First-level appeal (internal reconsideration): Your initial formal response to the denial. This is typically reviewed by a clinical reviewer or nurse reviewer at the payer — someone who may not have been involved in the original denial decision. The first-level appeal is your opportunity to present the clinical case with supporting evidence and address the specific reason for the denial.

Second-level appeal (internal appeal or review by medical director): If the first-level appeal is denied, you may request a second-level review. This is typically reviewed by a more senior clinical authority — often the payer's medical director or a physician specialist in the relevant clinical area. The second-level review considers the full file, including your original appeal, the first-level determination, and any additional evidence you submit.

External review: After exhausting internal appeals, most states allow you to request an independent external review by an outside organization. This is outside the payer's control and represents a truly independent assessment.

Not all payers offer two internal levels. Some move directly from the first internal appeal to external review eligibility. Your payer contracts and provider manuals specify the exact process for each insurer.

First-Level Appeal Strategy

The first-level appeal carries the highest probability of success for most denial types. According to AAPC analysis, a well-prepared first-level appeal overturns a significant portion of clinical denials, particularly when the initial denial resulted from incomplete documentation rather than a genuine disagreement about medical necessity.

Your first-level appeal should:

• Address the stated denial reason directly. Do not generalize. If the denial cited "insufficient documentation of medical necessity," your appeal should present the specific clinical evidence that demonstrates medical necessity. Quote the denial reason and respond to it point by point.
• Include patient-specific clinical evidence. Lab values, imaging results, functional assessments, treatment history — all with dates and objective measurements. The reviewer needs to see data, not assertions.
• Cite the payer's own criteria. Reference the payer's medical policy for the service in question and demonstrate how the patient meets each criterion. This is the most direct path to reversal at the first level.
• Reference published clinical guidelines. Cite guidelines from recognized medical organizations (ACR, NCCN, AGA, ASCO, etc.) that support the clinical decision. Include the guideline name, publishing organization, year, and specific recommendation.
• Keep it focused. The first-level appeal should be thorough but not exhaustive. Submit the clinical evidence that directly supports your case. Save additional arguments and supplementary literature for the second level if needed.

Second-Level Appeal Strategy

If the first-level appeal is denied, the second-level appeal must evolve beyond the initial submission. Simply resubmitting the same appeal letter with a note saying "please reconsider" is not a strategy — it is a formality that rarely changes outcomes.

The second-level appeal should:

• Address the first-level denial rationale. The first-level determination letter will explain why your appeal was denied. This is new information that must be addressed directly. If the reviewer said the clinical data was insufficient, provide additional data. If the reviewer said the patient does not meet criterion three of the medical policy, address criterion three specifically.
• Introduce new evidence. Additional clinical documentation, updated lab results, specialist consultation notes, peer-reviewed literature not included in the first appeal — the second level should include material that was not in the original submission. A second-level reviewer who sees the exact same file as the first-level reviewer has no new basis for reaching a different conclusion.
• Elevate the clinical argument. If the first-level appeal focused on guideline citations and objective data, the second level may benefit from a detailed clinical narrative from the treating physician explaining the clinical reasoning in the specific context of this patient's case. Why is this treatment necessary for this patient? What are the risks of the alternative the payer is suggesting? What does the clinical trajectory look like without the requested service?
• Consider a letter of medical necessity from a specialist. A supporting letter from a colleague in the same or related specialty can add credibility, particularly if the case involves clinical complexity or an unusual presentation. The specialist should provide an independent clinical assessment, not merely co-sign the treating physician's letter.
• Reference the standard of care. If the payer's position is inconsistent with the accepted standard of care in your specialty, make that argument explicitly. Cite multiple sources — guidelines, literature, and expert consensus — to establish that the payer's criteria do not reflect current clinical practice.

When to Escalate (and When Not To)

Not every denied first-level appeal should be escalated to the second level. The decision to escalate should consider:

• Dollar value of the denied claim. The staff time and physician time required for a second-level appeal has a cost. For low-dollar denials, the economics may not justify escalation.
• Strength of the clinical case. If your first-level appeal included strong clinical evidence and was still denied, you need to honestly assess whether additional evidence can change the outcome. If the denial is based on a medical policy exclusion that clearly applies, escalation may not be productive.
• First-level denial rationale. If the first-level reviewer identified a specific gap in your evidence, and you can fill that gap, escalation is worthwhile. If the reviewer upheld the denial on the same basis as the original decision without identifying any specific deficiency, the second level may review with a fresh perspective.
• Payer behavior patterns. Some payers are known to deny first-level appeals routinely but overturn at the second level. Your denial metrics should reveal these patterns over time. If a payer overturns 40% of second-level appeals, escalation is clearly worthwhile.
• Precedent value. Some denials have implications beyond the individual claim. If a payer is denying a service that is standard of care for your specialty, successfully overturning the denial sets a precedent that may reduce future denials for the same service.

External Review: The Final Internal Lever

When internal appeals are exhausted, external review through an Independent Review Organization (IRO) becomes available. External review is genuinely independent — the reviewer has no financial relationship with the payer and evaluates the case based solely on the clinical merits.

External review is particularly effective for cases where the clinical evidence is strong but the payer's internal reviewers have applied medical policy criteria that are inconsistent with published guidelines. The IRO reviewer applies an objective clinical standard, not the payer's proprietary criteria.

Building a Tiered Approach

The most effective denial management programs treat the appeal process as a deliberate escalation strategy, not a repetitive exercise in resubmission. Each level should build on the previous one, introduce new evidence, address new objections, and strengthen the clinical argument. This tiered approach maximizes the probability of reversal at each level while preserving your strongest arguments for the levels where they will have the most impact.

The practices that succeed at appeals are not the ones that submit the most paper. They are the ones that understand what each level requires and calibrate their response accordingly.